The patent was jointly filed by Dr. Emmanuelle Charpentier and ERS Genomics, Ireland, of which she is a co-founder. It contains a wide range of claims.
ERS news release, June 15, 2018
Ireland’s ERS Genomics obtains broad claims in Japan for CRISPR/Cas9 basic patent